Related Experiment Video
Updated: Jul 5, 2026
08:49
Use of Two Intracorporeal Ventricular Assist Devices As a Total Artificial Heart
Published on: May 11, 2018
Extreme heart makeover: understanding mechanical circulatory support.
1Penn State's Milton S. Hershey Medical Center, Hershey, PA, USA.
Nursing
|April 24, 2008
Summary
Ventricular assist devices and total artificial hearts are advanced treatments for heart failure. These devices significantly impact patient care and quality of life.
Area of Science:
- Cardiology
- Medical Devices
- Surgical Technology
Background:
- End-stage heart failure necessitates advanced therapeutic options.
- Ventricular assist devices (VADs) and total artificial hearts (TAHs) offer life-saving interventions.
- Understanding their impact on patient care is crucial for clinical practice.
Purpose of the Study:
- To provide an overview of ventricular assist devices (VADs) and total artificial hearts (TAHs).
- To explore the multifaceted effects of VADs and TAHs on patient care.
- To highlight key considerations for managing patients with these advanced cardiac support systems.
Main Methods:
- Review of current literature on VADs and TAHs.
- Analysis of clinical outcomes and patient management strategies.
- Synthesis of data regarding device implantation and long-term support.
Main Results:
- VADs and TAHs have demonstrated improved survival rates for eligible heart failure patients.
- Significant improvements in functional capacity and quality of life are observed.
- Management requires a multidisciplinary approach, addressing physiological and psychological aspects.
Conclusions:
- Ventricular assist devices and total artificial hearts represent critical advancements in treating advanced heart failure.
- These devices profoundly influence patient care, necessitating specialized medical and nursing support.
- Continued research and technological innovation are vital for optimizing outcomes and expanding patient eligibility.
Related Concept Videos
01:22Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
01:29Cardiomyopathy V: Interprofessional Care
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
01:30Cardiomyopathy II: Dilated Cardiomyopathy
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
01:29Cardiomyopathy III: Hypertrophic Cardiomyopathy
Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
01:30Heart Failure V: Medical Management
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...